The Biggest Growth Opportunity for ASCs Kicks off in 2026
Ambulatory surgery centers are seeing new growth opportunities as CMS expands the ASC Covered Procedures List by adding over 280 procedures. ASCs must plan and not expand too quickly, which can strain operations, staffing, and long term performance. This blog explains why strategic, phased ASC growth matters, what risks leaders should evaluate, and how to align expansion with operational readiness.
The CMS Code Expansion Is Changing the ASC Landscape
The Centers for Medicare and Medicaid Services continues to move care out of hospital settings by expanding the ASC payment system and covered procedures information
and phasing out the inpatient only list. This shift allows ASCs to consider higher acuity procedures and broader service lines than ever before.
For many organizations, this feels like a green light to grow quickly. More approved procedures can mean increased demand, new physician interest, and expanded patient access. However, adding these new procedures does not guarantee operational success.
Why Fast Expansion Creates Operational Risk
ASC growth is not just about adding physicians and procedures. It requires alignment across clinical operations, staffing, infrastructure, and market demand. When expansion happens faster than an organization’s ability to support it, problems often follow.
Common challenges include:
- Operational strain from unfamiliar procedures and workflows
- Staffing gaps or burnout when teams are stretched too thin
- Inefficient scheduling and throughput issues
- Inconsistent patient experience as complexity increases
Growth without preparation can dilute quality and create internal friction that is difficult to unwind later.
Infrastructure and Readiness Matter More Than Speed
Adding new service lines often requires changes in clinical protocols, supply management, and care coordination. Without time to test and refine these systems, ASCs may experience disruptions that affect both staff and patients.
Leaders should assess whether their current infrastructure can support expanded acuity and volume. This includes operating room turnover processes, post anesthesia care capacity, documentation workflows, and physician alignment. Expansion should strengthen the organization, not expose weak points.
Market Fit Is Critical for Sustainable Growth
Not every market can support every service line. Successful ASC expansion is grounded in local demand, referral patterns, and competitive dynamics. Growing too quickly in the wrong market can lead to underutilized capacity and operational inefficiencies.
A strategic approach evaluates:
- Local patient demand and physician alignment
- Competitive presence of hospitals and other ASCs
- Payer and regulatory environment
- Long term service line sustainability
Intentional growth focuses on the right services in the right markets at the right time.
What This Means Operationally in 2026
The 2026 expansion of the ASC Covered Procedures List materially changes how ASC leaders should think about operational planning. Many of the newly approved procedures carry higher acuity, longer case times, and materially higher Medicare facility reimbursement, which increases both opportunity and risk.
Operational implications ASC leaders should plan for include:
- Case mix complexity will increase. Procedures such as lumbar fusion, EP ablations, and neurostimulation implants require tighter clinical protocols and longer recovery monitoring.
- Staffing models may need to evolve as higher acuity cases demand more experienced anesthesia, nursing, and PACU resources.
- Throughput and scheduling discipline becomes critical as longer cases raise the cost of inefficiency and delays.
- Capital and supply planning must be proactive due to implants, devices, and inventory requirements.
- Phased implementation reduces risk and allows teams to refine workflows before scaling.
- Pre authorization and revenue cycle procedures are critical to getting reimbursed for neurostimulation implants and other procedures and devices.
Examples of high impact procedures newly approved for ASC settings in 2026 include:
- CPT 22630: Posterior lumbar interbody fusion (ASC facility fee approximately $20,858)
- CPT 22558: Anterior lumbar interbody fusion (ASC facility fee approximately $20,101)
- CPT 93656: EP ablation for atrial fibrillation (ASC facility fee approximately $20,256)
- CPT 93653: EP ablation for supraventricular tachycardia (ASC facility fee approximately $19,176)
- CPT 61891: Revision or replacement of cranial neurostimulator (ASC facility fee approximately $26,902)
Strategic Expansion vs Reactive Expansion
The most resilient ASCs are not reacting to policy changes alone. They are using CMS updates as one data point within a broader strategic framework.
Strategic expansion typically includes:
- Phased service line rollout
- Clear clinical leadership and accountability
- Operational readiness assessments before launch
- Ongoing performance monitoring and adjustment
This approach allows organizations to capture opportunity while maintaining consistency, quality, and control.
G2 Group Perspective on ASC Growth
At G2 Group, we work with ASC leaders to align growth strategies with operational realities. Expansion should support long term performance, not create short term disruption. As CMS policies evolve, disciplined planning and execution will separate successful operators from those struggling to keep up.
Growth works best when it is intentional, measured, and aligned with the organization’s capacity to deliver high quality care.
Frequently Asked Questions
Should ASCs expand simply because new procedures are approved by CMS?
No. CMS approval creates opportunity, but expansion should only occur when operational readiness, staffing, and market demand are aligned.
What is the biggest risk of expanding too quickly?
Operational strain is the most common issue. New procedures introduce complexity that can disrupt workflows, staffing balance, and patient experience if not properly planned.
How can ASCs evaluate readiness for expansion?
Readiness evaluations should include operational capacity, clinical expertise, leadership structure, infrastructure, and market demand.
Is phased growth better than launching multiple service lines at once?
Yes. Phased growth allows teams to adapt, refine processes, and maintain quality as complexity increases.
How should ASC leaders think about growth in 2026 and beyond?
Growth should be viewed as a strategic process, not a reaction to policy change. Long term success comes from alignment, preparation, and disciplined execution.
The CMS code expansion presents real opportunity for ASCs, but long term success depends on how intentionally that growth is executed. Organizations that align expansion with operational readiness, market demand, and leadership capacity will be best positioned to scale without disruption.
If your ASC is evaluating growth or new service lines, G2 Group can help you assess readiness and build a strategic path forward.
Connect with our team to start the conversation.